RaySearch Laboratories AB announced today that the new software solution SharePlan™ has been launched on the market. SharePlan™ is the first product emanating from a collaboration that was entered between RaySearch and TomoTherapy in 2007. As previously announced, the product received 510(k) clearance in January and now TomoTherapy will start taking orders.
SharePlan™ is an advanced treatment planning solution that enables transfer of treatment plans between TomoTherapy® Hi•Art® systems and conventional linear accelerators. The product uses highly sophisticated algorithms to automatically generate a selection of deliverable high-quality IMRT plans based on an existing Hi•Art® plan. This time-saving concept is an important tool for optimizing patient benefit and throughput at clinics that are introducing a Hi-Art® system into an environment with existing conventional linear accelerators.
“SharePlan is the tenth RaySearch product to be introduced on the market overall. This is the second product launch in 2009 and will be followed by several other products with different partners later in the year”, says Johan Löf, President of RaySearch.
ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners such as Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Ten products have been launched to date and RaySearch’s software is used at over 1,300 clinics in more than 30 countries. In addition, existing license agreements cover more than 15 other products that are scheduled to be launched in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the SmallCap segment on the OMX Nordic Exchange Stockholm.
For more information about RaySearch, please visit www.raysearchlabs.com.
Press releases
